MedTrace Logo

Cognitive Behavior Therapy for Patients With Psychoses.

NCT03501888 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-04-18

No results posted yet for this study

Summary

Patients with psychoses are randomized either to group treatment (ACT) or individual CBT for 18 sessions.

Conditions

  • Schizophrenia Spectrum and Other Psychotic Disorders

Interventions

BEHAVIORAL

Cognitive Behavior Therapy

18 sessions of individual treatment, no manual.

BEHAVIORAL

Acceptance and Commitment Therapy

18 sessions of group treatment, manual based.

Sponsors & Collaborators

Principal Investigators

  • Helena Fatouros-Bergman, PhD · Karolinska Insitutet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-08-31
Completion
2016-08-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03501888 on ClinicalTrials.gov